Magnesium modulates the expression levels of calcification-associated factors to inhibit calcification in a time-dependent manner

Xu,Jinsheng; Bai,Yaling; Jin,Jingjing; Zhang,Junxia; Zhang,Shenglei; Cui,Liwen; Zhang,Huiran

doi:10.3892/etm.2015.2215

Magnesium modulates the expression levels of calcification-associated factors to inhibit calcification in a time-dependent manner

Authors:
- Jinsheng Xu
- Yaling Bai
- Jingjing Jin
- Junxia Zhang
- Shenglei Zhang
- Liwen Cui
- Huiran Zhang
View Affiliations

Affiliations: Department of Nephrology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China
Published online on: January 26, 2015 https://doi.org/10.3892/etm.2015.2215
Pages: 1028-1034

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vascular calcification, a common complication in patients with chronic kidney disease, involves a variety of mechanisms associated with the regulation of calcification‑associated factors. Previous clinical studies have indicated that magnesium is involved in the reduction of vascular calcification; however, the mechanism underlying this process remains unknown. The aim of the present study was to investigate the effects of magnesium on β‑glycerophosphate (β‑GP)-induced calcification and the underlying mechanisms. Primary rat vascular smooth muscle cells (VSMCs) were exposed to 10 mM β‑GP in medium with or without the addition of 3 mM magnesium or 2‑aminoethoxy‑diphenylborate (2‑APB; an inhibitor of magnesium transport), for a 14‑day period. Calcium deposition and alkaline phosphatase (ALP) activity were measured by Alizarin red staining, quantification of calcium and enzyme‑linked immunosorbent assay. The expression levels of core‑binding factor α‑1 (Cbfα1), matrix Gla protein (MGP) and osteopontin (OPN) were determined by reverse transcription‑polymerase chain reaction or western blot analysis, following incubation for 0, 3, 6, 10 and 14 days with the different media. VSMC calcification and ALP activity was reduced significantly in the high‑magnesium medium compared with the calcification medium, during the 14‑day incubation. The magnesium‑induced changes in the VSMCs included a β‑GP‑induced downregulation of Cbfα1 by day 3 of incubation, an effect that was gradually enhanced over the 14‑day period. By contrast, magnesium produced notable increases in MGP and OPN expression levels, with an opposite pattern to that observed in the Cbfα1 expression levels. However, the addition of 2‑APB appeared to inhibit the protective effect of magnesium on the VSMCs. Therefore, magnesium was able to effectively reduce β‑GP‑induced calcification in rat VSMCs by regulating the expression levels of calcification‑associated factors in a time‑dependent manner.

View Figures

View References

1	Foley RN and Parfrey PS: Cardiovascular disease and mortality in ESRD. J Nephrol. 11:239–245. 1998.PubMed/NCBI
2	Goodman WG, Goldin J, Kuizon BD, et al: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 342:1478–1483. 2000. View Article : Google Scholar : PubMed/NCBI
3	Blacher J, Guerin AP, Pannier B, Marchais SJ and London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 38:938–942. 2001. View Article : Google Scholar : PubMed/NCBI
4	Scatena M, Liaw L and Giachelli CM: Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol. 27:2302–2309. 2007. View Article : Google Scholar : PubMed/NCBI
5	O’Neill WC: Mineral complexes and vascular calcification. Kidney Int. 76:915–916. 2009. View Article : Google Scholar
6	Zarjou A, Jeney V, Arosio P, et al: Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells. J Am Soc Nephrol. 20:1254–1263. 2009. View Article : Google Scholar : PubMed/NCBI
7	Geiger H and Wanner C: Magnesium in disease. Clin Kidney J. 5(Suppl 1): i25–i38. 2012. View Article : Google Scholar
8	Spiegel DM and Farmer B: Long-term effects of magnesium carbonate on coronary artery calcification and bone mineral density in hemodialysis patients: a pilot study. Hemodial Int. 13:453–459. 2009. View Article : Google Scholar : PubMed/NCBI
9	Massy ZA and Drüeke TB: Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J. 5(Suppl 1): i52–i61. 2012. View Article : Google Scholar
10	Louvet L, Büchel J, et al: Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant. 28:869–878. 2013. View Article : Google Scholar :
11	Kircelli F, Peter ME, Sevinc Ok E, et al: Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant. 27:514–521. 2012. View Article : Google Scholar :
12	Cai Y, Teng X, Pan CS, Duan XH, Tang CS and Qi YF: Adrenomedullin up-regulates osteopontin and attenuates vascular calcification via the cAMP/PKA signaling pathway. Acta Pharmacol Sin. 31:1359–1366. 2010. View Article : Google Scholar : PubMed/NCBI
13	Carbone L: Pain management standards in the eighth edition of the Guide for the Care and Use of Laboratory Animals. J Am Assoc Lab Anim Sci. 51:322–328. 2012.PubMed/NCBI
14	Mizobuchi M, Towler D and Slatopolsky E: Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol. 20:1453–1464. 2009. View Article : Google Scholar : PubMed/NCBI
15	Pun PH, Smarz TR, Honeycutt EF, Shaw LK, Al-Khatib SM and Middleton JP: Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int. 76:652–658. 2009. View Article : Google Scholar : PubMed/NCBI
16	Tzanakis I, Pras A, Kounali D, et al: Mitral annular calcifications in haemodialysis patients: a possible protective role of magnesium. Nephrol Dial Transplant. 12:2036–2037. 1997. View Article : Google Scholar : PubMed/NCBI
17	Tzanakis I, Virvidakis K, Tsomi A, et al: Intra- and extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes Res. 17:102–108. 2004.PubMed/NCBI
18	Turgut F, Kanbay M, Metin MR, Uz E, Akcay A and Covic A: Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol. 40:1075–1082. 2008. View Article : Google Scholar : PubMed/NCBI
19	Montezano AC, Zimmerman D, Yusuf H, et al: Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension. 56:453–462. 2010. View Article : Google Scholar : PubMed/NCBI
20	Jono S, McKee MD, Murry CE, et al: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 87:E10–E17. 2000. View Article : Google Scholar : PubMed/NCBI
21	Sun Y, Byon CH, Yuan K, et al: Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification. Circ Res. 111:543–552. 2012. View Article : Google Scholar : PubMed/NCBI
22	Zhong H, Liu F, Dai X, Zhou L and Fu P: Sodium thiosulfate protects human aortic smooth muscle cells from osteoblastic transdifferentiation via high-level phosphate. Kaohsiung J Med Sci. 29:587–593. 2013. View Article : Google Scholar : PubMed/NCBI
23	Steitz SA, Speer MY, Curinga G, et al: Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 89:1147–1154. 2001. View Article : Google Scholar : PubMed/NCBI
24	Moe SM, Duan D, Doehle BP, O’Neill KD and Chen NX: Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int. 63:1003–1011. 2003. View Article : Google Scholar : PubMed/NCBI
25	Luo G, Ducy P, McKee MD, et al: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 386:78–81. 1997. View Article : Google Scholar : PubMed/NCBI
26	Boström K, Tsao D, Shen S, Wang Y and Demer LL: Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem. 276:14044–14052. 2001.PubMed/NCBI
27	Wada T, McKee MD, Steitz S and Giachelli CM: Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res. 84:166–178. 1999. View Article : Google Scholar : PubMed/NCBI
28	Speer MY, McKee MD, Guldberg RE, et al: Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med. 196:1047–1055. 2002. View Article : Google Scholar : PubMed/NCBI
29	He Y, Yao G, Savoia C and Touyz RM: Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: role of angiotensin II. Circ Res. 96:207–215. 2005. View Article : Google Scholar
30	Paravicini TM, Chubanov V and Gudermann T: TRPM7: a unique channel involved in magnesium homeostasis. Int J Biochem Cell Biol. 44:1381–1384. 2012. View Article : Google Scholar : PubMed/NCBI